جست‌وجوی استاد و پژوهشگر

• Child Language Disorders
• Developmental Language Disorder
• Autism Spectrum Disorder
• +۵ مورد دیگر

Nicole Magaldi is a Professor in the Department of Communication Sciences and Disorders at Long Island University, School of Health Professions. With over 20 years of clinical experience in hospitals, early intervention, schools, and private practice, she brings a strong applied perspective to her academic work. Her expertise centers on child language disorders, particularly Developmental Language Disorder and Autism Spectrum Disorder. Educational Background: B.S., Cortland University M.A., Kean University Ph.D., New York University Dr. Magaldi's research focuses on evidence-based practice in child language disorders, clinical education methods, and the impact of reproductive factors on neurodevelopmental outcomes. She has published extensively on terminology navigation, pedagogical tools like problem-based learning, and early identification of autism. Her work bridges clinical practice and academic training, emphasizing practical solutions for clinicians and educators. The recent publications highlight a growing interest in integrating educational strategies with clinical rigor, particularly in training future speech-language pathologists. Her research also explores environmental and reproductive risk factors associated with Autism Spectrum Disorder, contributing to broader public health understanding. Scientific Awards: Dissertation of the Year, New York University Dr. Magaldi is actively involved in professional development through her membership in the American Speech-Language-Hearing Association (ASHA) and service on the Professional Development Committee for ASHA’s Special Interest Group 1 (SIG 1). While specific grant details are not listed, her sustained research output suggests ongoing scholarly and possibly funded activity. She mentors graduate students through research collaboration and clinical supervision, though no named advisees are listed. She is affiliated with the Department of Communication Sciences and Disorders, which operates under the School of Health Professions at LIU. Her work contributes to both clinical innovation and academic advancement in speech-language pathology.

• Physical Activity
• Fall Prevention
• Healthy Ageing
• +۳ مورد دیگر

Dr Juliana Souza de Oliveira is a Postdoctoral Research Fellow at the Institute for Musculoskeletal Health , a partnership between the University of Sydney and Sydney Local Health District. She holds an Adjunct Senior Lecturer position at the Sydney School of Public Health , Faculty of Medicine and Health. Her research focuses on physical activity interventions to promote healthy ageing and prevent falls in older populations, particularly through yoga and digital health (teleyoga) programs. Primary Affiliation: University of Sydney Sub-Affiliation: Sydney School of Public Health Research Partners: Sydney Local Health District, WHO, NHMRC Research Themes include fall prevention , healthy ageing , digital health interventions , and physical activity promotion . Her work spans clinical trials, systematic reviews, and meta-analyses, with a focus on community-dwelling older adults. Recent Publications (2024-2015) address topics such as fall risk factors , yoga-based interventions , sarcopenia in chronic kidney disease , cost-effectiveness of exercise programs , and teleyoga adoption during pandemics . These studies employ methodologies like randomised controlled trials , systematic reviews , and realist evaluations . Scientific Awards and Grants include funding from the Physiotherapy Research Foundation , NHMRC , and AHRA Women's Health Research Network . Her work also intersects with organisations like the Australian Association of Gerontology and International Society of Behavioral Nutrition & Physical Activity (ISBNPA) . Advisory and Collaborative Efforts extend to Charlotte KILMARTIN and Ima STRKLJEVIC , with whom she explores inpatient fall reduction and physiotherapist-led activity promotion . She collaborates extensively on NHMRC-funded trials and WHO guideline development .

William Templeمشاهده پروفایل

پزشک-پژوهشگر

• Pediatric blood & marrow transplantation
• Cancer immunotherapy
• Pediatric oncology
• +۴ مورد دیگر

Dr. William Temple is a clinical-translational physician-scientist at the University of California San Francisco specializing in pediatric blood & marrow transplantation (BMT), cancer immunotherapy, and pediatric oncology. As an attending physician at UCSF Benioff Children's Hospitals in both San Francisco and Oakland, he focuses on translating novel immunotherapies from bench to bedside through first-in-human and first-in-child clinical trials for patients with aggressive malignancies. His current position is Advanced Fellow in Pediatric Blood & Marrow Transplantation and Immunotherapy at UC San Francisco (since July 2024). Temple's research interests center on developing innovative CAR-T cell therapies, particularly CD72-targeting nanobody CAR-T cells for B-cell malignancies. He is deeply engaged in correlative biology analyses to evaluate biomarkers of response and resistance to new cancer immunotherapy products. His work bridges laboratory discoveries with clinical applications, focusing on patients with relapsed/refractory B-cell malignancies and other aggressive cancers. His publications demonstrate a clear trend toward optimizing CAR-T cell therapies through affinity maturation and framework humanization to enhance efficacy against tumors with low antigen density. His research spans both hematologic malignancies and solid tumors, with particular emphasis on developing more effective immunotherapies for pediatric patients who have limited treatment options. Physician-Scientist Fellowship, California Institute of Regenerative Medicine Alpha Stem Cell Clinic Renewal (2025-2026) New Investigator Award, American Society of Transplantation and Cellular Therapy (2024-2026) Center of Excellence Scholar, Alex's Lemonade Stand Foundation (2024-2025) Physician-Scientist Fellowship, California Institute of Regenerative Medicine Alpha Stem Cell Clinic (2024-2025) Clinical Research Training Institute Scholar, American Society of Hematology (2023-2024) Temple serves as Principal Investigator on multiple significant research grants from the National Institutes of Health, Chan Zuckerberg Biohub, American Society of Hematology, American Society of Transplantation and Cellular Therapy, California Institute of Regenerative Medicine, and Alex's Lemonade Stand Foundation. His current projects include CD72 nanoCARs for treatment of relapsed/refractory B cell malignancies and research on Alpha Stem Cell Clinic physician-scientist fellowships. He also contributes to research on pharmacokinetic modeling to optimize drug dosing in pediatric transplantation.

• Cardiac Imaging
• Magnetic Resonance Imaging
• Computed Tomography
• +۶ مورد دیگر

Ronald M Peshock is a Professor of Radiology and Internal Medicine at the University of Texas Southwestern Medical Center (UTSW), with a career spanning over four decades since completing medical school at UT Southwestern in 1976. His academic journey includes Internal Medicine training at Parkland Health & Hospital System (internship 1977, residency 1979) followed by a Cardiology fellowship (1982). Dr. Peshock's research focuses on cardiac imaging, particularly using MRI and CT technologies to assess cardiovascular risk and disease. His work heavily involves the Dallas Heart Study, examining left ventricular hypertrophy, atherosclerosis, and cardiovascular risk factors across diverse populations. In recent years, he has become a prominent researcher in artificial intelligence applications for radiology, with numerous publications on AI implementation in clinical workflows, diagnostic accuracy improvement, and integration of AI into radiology training programs. His publication record shows consistent productivity from 1979 through 2025, with 218 total publications according to available records. Recent work demonstrates particular expertise in cardiac CT, pulmonary embolism imaging, and developing quantitative imaging biomarkers for cardiovascular disease. His Scopus profile indicates an h-index of 67 with 14,914 citations, reflecting significant scholarly impact in his fields. Dr. Peshock maintains active clinical and research affiliations with Parkland Health & Hospital System and serves as a key researcher in the Dallas Heart Study. His work examining ethnic differences in cardiovascular disease, left ventricular hypertrophy patterns, and aortic stiffness has contributed significantly to cardiovascular imaging literature.

• Sarcoma Immunotherapy
• Osseointegration
• Limb Salvage
• +۴ مورد دیگر

Dr. Rosanna Wustrack is a Professor of Orthopaedic Surgery at the University of California, San Francisco (UCSF) School of Medicine, where she serves as the Chief of Orthopedic Oncology. She specializes in the surgical diagnosis and treatment of musculoskeletal tumors and fragility fractures, with a focus on limb salvage procedures and complex reconstructive surgery. Her educational background includes a BA in Biology from Yale University (1999), an MD from Washington University School of Medicine in St. Louis (2006), residency in Orthopedic Surgery at UCSF (2012), fellowship in Musculoskeletal Oncology at Memorial Sloan Kettering Cancer Center (2013), and Advanced Training in Clinical Research from UCSF (2014). She also completed Diversity, Equity, and Inclusion Champion Training at UCSF in 2018. Dr. Wustrack's research focuses on immunotherapy for sarcomas, functional outcomes in cancer patients, osseointegration, and optimizing treatment for metastatic disease. Her work also extends to global health initiatives and addressing osteoporosis in cancer survivors. She has made significant contributions to understanding tumor immunology, developing innovative reconstructive techniques, and improving outcomes for patients with musculoskeletal tumors. Her extensive publication record demonstrates expertise across sarcoma biology, orthopedic oncology, and innovative reconstructive techniques. The articles reveal a strong emphasis on translational research, with particular focus on sarcoma immunology, osseointegration technology, and outcomes research in musculoskeletal oncology. Her work bridges basic science with clinical applications, particularly in developing novel approaches to sarcoma treatment and improving prosthetic integration. UCSF Department of Orthopedic Surgery 2012 Mauer Chief Resident of the Year UCSF Department of Orthopedic Surgery 2016 James O. Johnston Resident Teaching Award UCSF Academy of Medical Educators 2018 Excellence in Teaching Award Musculoskeletal Research Society 2019-2020 Mentored Research Award UCSF Department of Orthopedic Surgery 2020 Compassionate Physician Award UCSF Health 2020 Exceptional Physician Award Dr. Wustrack serves as Principal Investigator on the Musculoskeletal Tumor Society grant "Identifying and enhancing the host immune response in adult soft tissue sarcoma" and as Co-Investigator on Department of Defense-funded research on osseointegration and neural-controlled prosthetics. Her work with the UCSF Sarcoma Center and Osseointegration Program (iCORES) demonstrates her commitment to multidisciplinary approaches to complex oncologic problems. She is actively involved in global health initiatives through the Institute for Global Health Sciences, focusing on improving surgical care access worldwide.

• posttraumatic stress disorder
• prolonged grief disorder
• global mental health
• +۵ مورد دیگر

Scientia Professor Richard Bryant is a leading researcher in trauma psychology at the University of New South Wales, where he serves in the School of Psychology. With over three decades of research experience, he has established himself as a world authority on posttraumatic stress disorder (PTSD), prolonged grief disorder, and trauma-related mental health conditions. Professor Bryant received his B.A. (Hons.) from the University of Sydney in 1983, followed by his M.Clin. Psych. and Ph.D. from Macquarie University in 1986 and 1989 respectively. He was awarded a D.Sc. from UNSW in 2016, recognizing his substantial contributions to the field. His clinical training and academic background have positioned him at the forefront of trauma research and treatment development. Dr. Bryant's research primarily focuses on posttraumatic stress disorder, prolonged grief disorder, global mental health initiatives, cognitive behavior therapy applications, and clinical trials methodology. His work spans diverse populations including trauma survivors, refugees, first responders, and individuals affected by disasters. He has pioneered early intervention approaches following traumatic events and developed innovative treatments for persistent trauma reactions across various cultural contexts. An analysis of his recent publications reveals a strong emphasis on global mental health applications, particularly in conflict zones and with displaced populations. His research increasingly incorporates digital health solutions, examines cultural variations in trauma response, and investigates novel treatment approaches including memory specificity training and integration of technology in therapy delivery. His work consistently bridges clinical practice with research evidence to improve mental health outcomes worldwide. Professor Bryant maintains an active research program with numerous ongoing clinical trials and international collaborations. His work has significantly influenced clinical guidelines for trauma treatment globally, particularly through his contributions to World Health Organization interventions and evidence-based practice recommendations. Based at the University of New South Wales in Sydney, Professor Bryant continues to mentor emerging researchers while maintaining a robust publication record that demonstrates both depth and breadth across trauma psychology domains. His Mathews Building office serves as the hub for a productive research team investigating critical questions in trauma response and recovery.

• Abdominal Imaging
• Body Imaging
• LI-RADS (Liver Imaging Reporting and Data System)
• +۴ مورد دیگر

Tasneem Kassam Lalani serves as an Associate Professor of Radiology at UMass Chan Medical School, specifically within the T.H. Chan School of Medicine. She specializes in Abdominal Imaging and maintains an active clinical and academic presence at the institution. Education Background: BS in Zoology from University of British Columbia, Vancouver, BC, Canada MS in Physiology/Respiratory Biology from Harvard University, Cambridge, MA, United States MD from University of Alberta, Edmonton, AB, Canada Internship (Rotating) at Greater Victoria Hospitals, University of British Columbia, Victoria, BC, Canada Residency in Radiology at M.D. Anderson Cancer Center, University of Texas, Houston, TX Fellowship in Body Imaging at University of Toronto, Toronto, ON, Canada Mini Fellowship in Chest Radiology and HRCT at University of British Columbia, Vancouver, BC, Canada Dr. Lalani's research focuses primarily on abdominal imaging, with special expertise in liver imaging using the Liver Imaging Reporting and Data System (LI-RADS). Her work spans gastrointestinal radiology, oncologic imaging, and vascular imaging. She has made significant contributions to the American College of Radiology (ACR) Appropriateness Criteria, developing patient-friendly summaries for various clinical scenarios. Her research demonstrates a strong commitment to improving diagnostic accuracy, standardizing imaging protocols, and enhancing patient education in radiology practice. Analysis of her publication history reveals consistent contributions to abdominal imaging literature, with recent emphasis on implementation strategies for LI-RADS, technical optimization of CT/MRI for liver imaging, and development of patient-friendly imaging guidelines. Her work shows strong collaboration with national radiology experts and has been incorporated into clinical practice guidelines. Dr. Lalani serves as a key contributor to the ACR Appropriateness Criteria panels, particularly in areas related to abdominal imaging, gastrointestinal disorders, and liver disease. Her expertise is recognized through her numerous publications in high-impact radiology journals and her role in shaping evidence-based imaging guidelines. She maintains active collaborations with colleagues across multiple institutions, particularly in the development and implementation of standardized imaging protocols. Her work bridges clinical practice with academic research, focusing on practical applications that improve patient care and diagnostic accuracy in radiology.

Francesca Ievaمشاهده پروفایل

دانشیار

• Biostatistics
• Health Data Science
• Statistical Learning
• +۵ مورد دیگر

Francesca Ieva serves as Associate Head of the Health Data Science Centre at Human Technopole and Associate Professor of Statistics at the Politecnico di Milano, where she leads the MOX - Modeling and Scientific Computing laboratory within the Department of Mathematics. She also co-leads the Di Angelantonio & Ieva Group, a collaborative research team focused on integrating molecular data with clinical information to advance precision medicine. Dr. Ieva received her PhD in Mathematical Models and Methods for Engineering in 2012. Her academic journey has positioned her at the forefront of health data science, bridging statistical methodology with biomedical applications. Her research focuses on statistical learning in biomedical sciences, with particular emphasis on developing advanced models for integrating complex clinical data to inform predictions in clinical decision-making. Francesca's work spans multiple domains including: Development of novel survival analysis techniques for healthcare applications Integration of DNA methylation data for cardiovascular risk prediction Application of machine learning to clinical pathway analysis in mental health Innovative approaches to polygenic risk scoring incorporating SNP interactions Development of radiomics models for cancer prognosis and treatment response Analysis of Dr. Ieva's recent publications reveals a strong trend toward federated learning approaches in healthcare data analysis, reflecting growing concerns about data privacy while maintaining analytical power. Her work increasingly integrates multiple data types (genomic, epigenetic, imaging, and clinical records) to create more comprehensive patient profiles for precision medicine applications. A notable pattern is her focus on translating complex statistical models into clinically actionable tools that can directly inform patient care and healthcare policy decisions. As Associate Head of the Health Data Science Centre at Human Technopole, Dr. Ieva oversees a research group comprising epidemiologists, statisticians, and data scientists working collaboratively to bridge the gap between genotype and phenotype. The Di Angelantonio & Ieva Group develops innovative studies that integrate biomolecular data with medical records, imaging, and portable medical device data. Her team utilizes both existing healthcare data and newly generated population-based studies, applying novel analytical methods that integrate clinical epidemiology with health research to improve data interpretation. Dr. Ieva actively mentors several PhD students including Andrea Lampis, Katherine Marie Logan, Alessia Mapelli, Michela Carlotta Massi, and Andrea Mario Vergani. Her research has been supported by collaborations with major healthcare institutions and likely receives funding from research councils and health technology initiatives, though specific grant details are not provided in the available information.

Todd Smithermanمشاهده پروفایل

استاد

• Clinical Psychology
• Neurology
• Pain Management
• +۵ مورد دیگر

Todd Smitherman is a Professor of Psychology and Director of Clinical Training at the University of Mississippi within the College of Liberal Arts. He holds a PhD in Clinical Psychology from Auburn University (2006) and has focused his research on psychological factors in chronic medical conditions, particularly migraine and its psychiatric comorbidities. Education: BA in Psychology, Samford University (2000) PhD in Clinical Psychology, Auburn University (2006) Research Interests: Dr. Smitherman investigates migraine and headache disorders through the lens of psychological comorbidities (anxiety, depression, insomnia), behavioral triggers (poor sleep, stress), and interventions. His work includes exploring pain acceptance, fear of pain, and behavioral insomnia treatments for migraine reduction. Publications: Recent articles examine neuropsychological functioning in pediatric headache disorders, pain acceptance mechanisms in mindfulness-based therapies, and the impact of migraine aura on disability. His research employs daily diary studies, meta-analyses, and behavioral clinical trials. Teaching: Courses taught include Introduction to Psychology (PSY 201), Health Psychology (PSY 410), and graduate seminars on clinical assessment, research design, and ethics.

Brin Grenyerمشاهده پروفایل

استاد

• Clinical psychology
• Personality disorders
• Borderline Personality Disorder
• +۷ مورد دیگر

Brin Grenyer OAM is Senior Professor of Psychology at the University of Wollongong and Director of the Project Air Strategy for Personality Disorders, in partnership with NSW Health. He is an internationally recognised leader in the science and treatment of personality disorders and serves as President-Elect of the International Society for the Study of Personality Disorders (ISSPD) with a term spanning President-Elect (2022-23), President (2024-25), and Past President (2026-2027). Professor Grenyer maintains active clinical practice through the Northfields Psychology Clinic and consults widely on patient care issues across NSW, Australia, and internationally. Professor Grenyer's research program focuses on the psychotherapy treatment of chronic and complex psychological problems, with particular emphasis on personality disorders (especially Borderline Personality Disorder), self-harm, suicidal ideation, chronic depression, aggression and violence, early attachment relationships, and substance dependence. His methodological approach integrates quantitative clinical measures, biomedical assessments, psychotherapy process research, qualitative lived experience narratives, and longitudinal studies to develop comprehensive understanding of complex mental health conditions. Analysis of Professor Grenyer's recent publications reveals a sophisticated evolution in his research focus, with increasing attention to dimensional assessment frameworks like ICD-11, gender differences in personality pathology, digital interventions (particularly the Air Therapy program), telehealth delivery of psychotherapy, and implementation science approaches to integrate evidence-based treatments into healthcare systems. His work demonstrates a consistent commitment to bridging research evidence with clinical practice while incorporating lived experience perspectives. Professor Grenyer's scientific contributions have been recognized through significant awards: Medal of the Order of Australia (OAM) for service to psychology (2021) College of Clinical Psychologists Ian M Campbell Memorial Prize (2020) World top 1% (top 0.21%) of experts in Borderline Personality Disorder (2011-2021) Professor Grenyer has supervised numerous doctoral and master's students across a wide spectrum of topics related to personality disorders, self-harm, and psychotherapy processes. His research program has secured over 50 grants totaling more than $18 million in funding from diverse sources including NHMRC, university strategic funds, and health organizations. Major projects include the Air Therapy initiative, Project Air Strategy for Personality Disorders, and studies on lived experience perspectives in mental health services. Professor Grenyer directs the Project Air Strategy for Personality Disorders and maintains clinical involvement through the Northfields Psychology Clinic. His work uniquely integrates academic research, clinical practice, professional leadership (including his role as Foundation Chair of the Psychology Board of Australia from 2009-2018), and healthcare system implementation to advance the field of personality disorders treatment.

Jeremy M G Taylorمشاهده پروفایل

استاد

• Biostatistics
• Survival Analysis
• Longitudinal Data Analysis
• +۵ مورد دیگر

Jeremy M G Taylor is the Pharmacia Research Professor of Biostatistics and holds professorships in the Department of Radiation Oncology in the School of Medicine and the Department of Computational Medicine and Bioinformatics at the University of Michigan. He serves as the Associate Director for Biostatistics at the Comprehensive Cancer Center and directs both the University of Michigan Cancer Center Biostatistics Unit and the Cancer/Biostatistics training program. His educational background includes: B.A. in Honours Mathematics from Cambridge University (1978) Dip. Stat. in Statistics from Cambridge University (1979) PhD in Statistics from University of California, Berkeley (1983) Professor Taylor's research focuses on the theory and application of statistics to biomedical problems, with an emphasis on data-driven, robust, and flexible statistical methods that incorporate scientific knowledge from specific research domains. His theoretical interests span Box-Cox power transformations, robust methods, causal inference, nonparametrics, and smoothing techniques. His applied work centers on cancer and AIDS research, particularly in radiation oncology, where he has developed methods involving mixture models, stochastic processes, multistate models, and multiple imputation. His extensive publication record demonstrates a continued focus on survival analysis, longitudinal data modeling, biomarker evaluation, and clinical trial design. Recent work explores time-varying effects, joint modeling approaches, multiple imputation techniques, and the integration of external information into statistical models, with applications across various cancer types including prostate, head and neck, and liver cancers. Awarded the Mortimer Spiegelman Award from the American Public Health Association, the Michael Fry Award from the Radiation Research Society, and the Jerome Sacks Award from the National Institute of Statistical Sciences, Professor Taylor has established himself as a leading biostatistician in cancer research methodology. With over 35 years of academic experience (UCLA 1983-1998, University of Michigan 1998-present), Professor Taylor has maintained an active research program while mentoring numerous students and collaborating extensively with clinical researchers. His work bridges sophisticated statistical methodology with practical applications in cancer treatment and outcomes research. As director of the Cancer Center Biostatistics Unit and the Cancer/Biostatistics training program, he leads a significant research team focused on advancing statistical methods for cancer research and training the next generation of biostatisticians.

Christina A. Robertoمشاهده پروفایل

استاد

• Nutrition and Health Policy
• Public Health
• Behavioral Economics
• +۲ مورد دیگر

Christina A. Roberto, PhD , Mitchell J. Blutt and Margo Krody Blutt Presidential Professor of Health Policy at the Perelman School of Medicine, University of Pennsylvania. She directs the Psychology of Eating and Consumer Health (PEACH) Lab and serves as Associate Director of the Center for Health Incentives and Behavioral Economics at Penn. Current National Academy of Medicine Emerging Leader Fellow Robert Wood Johnson Foundation Health and Society Scholar Completed clinical internship at Yale School of Medicine Research Focus: The PEACH Lab addresses food policy and behavioral economics to combat nutrition-related chronic diseases, emphasizing health equity. Her work bridges academic research with real-world applications for policymakers, community organizations, and institutions. Nutrition policy development Behavioral economics in health Food environment interventions Health equity promotion Chronic disease prevention Scientific Recognition: Robert Wood Johnson Foundation Health and Society Scholar National Academy of Medicine Emerging Leader Fellow Email: croberto@pennmedicine.upenn.edu

Daphna Harelمشاهده پروفایل

دانشیار

• Survey Methodology
• Measurement Theory
• LGBTQIA+ Data Analysis
• +۶ مورد دیگر

Daphna Harel (she/her) serves as Associate Professor of Applied Statistics and Director of the A3SR MS Program within the Department of Applied Statistics, Social Science, and Humanities at New York University's Steinhardt School of Culture, Education, and Human Development. She holds leadership roles including PI of the NYU QUEER data lab and membership on the steering committee for the DEPRESSD project. Education: PhD in Mathematics and Statistics from McGill University Harel's research focuses on measurement challenges in survey methodology, particularly for self-reported questionnaires in health and social sciences. Her work bridges theoretical statistics with practical applications in LGBTQIA+ data collection, differential item functioning, and patient-reported outcomes. She develops methodological frameworks for polytomous Item Response Theory and creates guidelines for statistical analysis of complex survey data. Her recent work emphasizes improving statistical practice for LGBTQIA+ populations and advancing queer data collection methods. Her publication portfolio demonstrates consistent focus on measurement validity across diverse health contexts, with recent work expanding into LGBTQIA+ data science. Her research shows increasing emphasis on methodological innovations for gender and sexuality measurement, with multiple publications presented at major conferences including AAPOR 2024 and LGBTQ+ Health Conference 2024. Research Leadership: PI of NYU QUEER data lab (founded Fall 2022) Steering committee member for DEPRESSD project Collaborator with Scleroderma Patient-centered Intervention Network Recipient of NIH R21 funding and NYU intramural grants Harel mentors a diverse team of graduate students through the Applied Statistics for Social Science Research program, focusing on inclusive research methods for marginalized populations. Her grant portfolio includes investigations into transgender voice training, LGBTQIA+ survey methodology, and healthcare access for gender-affirming services. Laboratory Leadership: As founder and PI of the NYU QUEER data lab, Harel leads research projects examining survey question design for gender/sexuality measurement, content moderation effects on hate speech, and accessibility of transgender voice training. The lab operates through collaboration between NYU Steinhardt and the NYU BITS lab, with research assistants drawn from the Applied Statistics MS program.

Menno Douwesمشاهده پروفایل

استادیار بالینی

• Pediatric Cardiology
• Congenital Heart Diseases
• Pulmonary Hypertension
• +۳ مورد دیگر

Menno Douwes is a pediatric cardiologist and researcher at the University of Groningen's Faculty of Medical Sciences, specializing in Vascular Medicine. He holds both MD and PhD credentials, with his doctoral work focused on Pediatric Pulmonary Arterial Hypertension completed cum laude in 2017. His research interests center on advancing the field of congenital heart diseases, with special focus on pulmonary vascular and ventricular adaptation to abnormal loading conditions. His work contributes to UN Sustainable Development Goals related to health and well-being. Dr. Douwes has published extensively in the field of pediatric pulmonary hypertension, with research focusing on risk stratification, therapeutic approaches including prostanoids and pirfenidone, and innovative methods for assessing disease severity through physical activity monitoring. His recent work shows a strong emphasis on translating experimental findings into clinical practice. Dekkerbeurs research grant from Hartstichting (2023) Half-million euro research grant for pediatric cardiovascular research (2023) Dr. Douwes actively contributes to the academic community through organizing conferences including the 5th European Conference on Neonatal and Paediatric Pulmonary Vascular Disease (2023). His research has received significant attention with multiple publications garnering substantial citations and media coverage. His educational background includes a Medical Degree from the University of Groningen (2009), PhD in Pediatric Pulmonary Arterial Hypertension (2017), Pediatrician certification (2019), and Paediatric Cardiologist specialization (2022), demonstrating a dedicated career path in pediatric cardiovascular medicine.

Varun Vaidyaمشاهده پروفایل

استاد

• Pharmacoeconomics
• Health Outcomes Research
• Real-World Evidence
• +۳ مورد دیگر

Dr. Varun Vaidya is a Professor and the Director of B.S.P.S. Pharmacy Administration Program and M.S.P.S. Health Outcomes and Socioeconomic Sciences program in the Department of Pharmacy Practice at the University of Toledo College of Pharmacy and Pharmaceutical Sciences. He serves as the faculty advisor to the UT-ISPOR chapter and holds significant roles in national organizations including the Pharmacy Quality Alliance (PQA) Data & Interoperability Advisory Group (DIAG), ISPOR, APhA, and AACP. Dr. Vaidya's educational background includes: Ph.D. in Pharmacoeconomics from University of Tennessee, Memphis (2009) B.Pharm. from Bharati Vidyapeeth, India (2002) Certification in Measurement, Design and Analysis Methods for Health Outcomes Research from Harvard School of Public Health (2010) His research program centers on quantitative assessment of health outcomes related to medication use, with particular expertise in real-world evidence (RWE) studies that inform value-based decision making and outcomes-driven healthcare delivery. Dr. Vaidya has extensive experience with claims databases including Optum, GE, MarketScan, Truven, and Clinical Practice Research Datalink (CPRD) U.K., as well as U.S. national databases such as Medical Expenditure Panel Survey (MEPS), Behavioral Risk Factor Surveillance Survey (BRFSS), and National Health and Nutrition Examination Survey (NHANES). His publication record demonstrates a strong focus on pharmacoeconomics across multiple therapeutic areas including oncology (particularly lung cancer and myelofibrosis), diabetes management, mental health, opioid use disorder, and medication adherence patterns. His work frequently examines medication utilization patterns, healthcare costs, treatment effectiveness, and the impact of social determinants on health outcomes. Dr. Vaidya actively contributes to the academic and professional community through his role as program director, faculty advisor, and national organization participation. He is frequently invited to speak at national and international venues and provides expertise to media outlets on prescription drug pricing and pharmaceutical policy issues, having featured in news segments and authored Op-Ed articles on these topics.